Carnegie Investment Counsel’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $38.6M | Sell |
96,955
-7,877
| -8% | -$2.92M | 0.77% | 27 |
|
|
2026
Q1 | $27.2M | Sell |
104,832
-3,048
| -3% | -$908K | 0.53% | 57 |
|
|
2025
Q4 | $35.6M | Buy |
107,880
+2,259
| +2% | +$766K | 0.66% | 41 |
|
|
2025
Q3 | $36.5M | Buy |
105,621
+2,316
| +2% | +$700K | 0.69% | 36 |
|
|
2025
Q2 | $32.2M | Buy |
103,305
+8,474
| +9% | +$3.24M | 0.65% | 38 |
|
|
2025
Q1 | $49.7M | Buy |
94,831
+68,219
| +256% | +$34.9M | 1.18% | 16 |
|
|
2024
Q4 | $13.5M | Buy |
26,612
+56
| +0.2% | +$31.8K | 0.39% | 79 |
|
|
2024
Q3 | $15.5M | Buy |
26,556
+707
| +3% | +$400K | 0.46% | 63 |
|
|
2024
Q2 | $13.2M | Sell |
25,849
-4,899
| -16% | -$2.4M | 0.41% | 69 |
|
|
2024
Q1 | $15.2M | Sell |
30,748
-11,452
| -27% | -$5.82M | 0.47% | 60 |
|
|
2023
Q4 | $22.2M | Buy |
42,200
+413
| +1% | +$220K | 0.76% | 36 |
|
|
2023
Q3 | $21.1M | Buy |
41,787
+890
| +2% | +$438K | 0.81% | 31 |
|
|
2023
Q2 | $19.7M | Buy |
40,897
+1,804
| +5% | +$882K | 0.73% | 37 |
|
|
2023
Q1 | $18.5M | Buy |
39,093
+2,886
| +8% | +$1.39M | 0.74% | 39 |
|
|
2022
Q4 | $19.2M | Buy |
36,207
+5,907
| +19% | +$3.13M | 0.83% | 32 |
|
|
2022
Q3 | $15.3M | Buy |
30,300
+8,775
| +41% | +$4.61M | 0.73% | 36 |
|
|
2022
Q2 | $11.1M | Buy |
21,525
+7,001
| +48% | +$3.52M | 0.5% | 61 |
|
|
2022
Q1 | $7.41M | Buy |
14,524
+487
| +3% | +$235K | 0.27% | 102 |
|
|
2021
Q4 | $7.05M | Buy |
14,037
+1,291
| +10% | +$584K | 0.23% | 117 |
|
|
2021
Q3 | $4.98M | Sell |
12,746
-117
| -0.9% | -$48.5K | 0.19% | 130 |
|
|
2021
Q2 | $5.15M | Buy |
12,863
+39
| +0.3% | +$15.6K | 0.19% | 123 |
|
|
2021
Q1 | $4.77M | Sell |
12,824
-200
| -2% | -$69.3K | 0.2% | 125 |
|
|
2020
Q4 | $4.57M | Sell |
13,024
-163
| -1% | -$54.6K | 0.21% | 123 |
|
|
2020
Q3 | $4.11M | Sell |
13,187
-698
| -5% | -$214K | 0.21% | 121 |
|
|
2020
Q2 | $4.09M | Sell |
13,885
-1,004
| -7% | -$288K | 0.24% | 113 |
|
|
2020
Q1 | $3.71M | Sell |
14,889
-20
| -0.1% | -$5.5K | 0.26% | 109 |
|
|
2019
Q4 | $4.38M | Buy |
14,909
+34
| +0.2% | +$8.89K | 0.25% | 111 |
|
|
2019
Q3 | $3.23M | Buy |
14,875
+2,630
| +21% | +$635K | 0.21% | 127 |
|
|
2019
Q2 | $2.99M | Buy |
12,245
+4,400
| +56% | +$1.06M | 0.19% | 127 |
|
|
2019
Q1 | $1.94M | Sell |
7,845
-246
| -3% | -$62.7K | 0.13% | 151 |
|
|
2018
Q4 | $2.02M | Buy |
8,091
+5,959
| +280% | +$1.57M | 0.19% | 131 |
|
|
2018
Q3 | $577K | Sell |
2,132
-2,394
| -53% | -$623K | 0.05% | 235 |
|
|
2018
Q2 | $1.19M | Sell |
4,526
-838
| -16% | -$201K | 0.09% | 190 |
|
|
2018
Q1 | $1.28M | Sell |
5,364
-213
| -4% | -$48.6K | 0.11% | 168 |
|
|
2017
Q4 | $1.26M | Sell |
5,577
-155
| -3% | -$32.8K | 0.11% | 192 |
|
|
2017
Q3 | $1.19M | Buy |
5,732
+356
| +7% | +$68.8K | 0.14% | 173 |
|
|
2017
Q2 | $1.04M | Sell |
5,376
-22
| -0.4% | -$3.86K | 0.13% | 172 |
|
|
2017
Q1 | $936K | Buy |
5,398
+1,096
| +25% | +$179K | 0.12% | 178 |
|
|
2016
Q4 | $697K | Buy |
4,302
+1,609
| +60% | +$240K | 0.09% | 187 |
|
|
2016
Q3 | $361K | Hold |
2,693
| – | – | 0.05% | 241 |
|
|
2016
Q2 | $382K | Buy |
2,693
+350
| +15% | +$46.7K | 0.05% | 242 |
|
|
2016
Q1 | $302K | Hold |
2,343
| – | – | 0.05% | 252 |
|
|
2015
Q4 | $270K | Buy |
2,343
+188
| +9% | +$22K | 0.05% | 249 |
|
|
2015
Q3 | $257K | Buy |
+2,155
| New | +$258K | 0.04% | 254 |
|
Other funds holding UNH
PAM
Carnegie Investment Counsel's UNH Position: Q2 2026 in Review
Carnegie Investment Counsel reduced its UnitedHealth (UNH) stake by 7.5% in Q2 2026, selling an estimated $2.92M and leaving 96,955 shares worth $38.6M. The position accounts for 0.77% of the portfolio, ranked #27.
Carnegie Investment Counsel first reported a position in UNH in Q3 2015 and has held it in 44 quarters since. The position peaked at $49.7M in Q1 2025. 1,660 funds tracked by Wall St. Rank hold UNH as of Q2 2026.
- Carnegie Investment Counsel held 96,955 shares of UnitedHealth worth $38.6M as of Q2 2026.
- Carnegie Investment Counsel sold 7,877 UnitedHealth shares in Q2 2026, an estimated $2.92M.
- UnitedHealth made up 0.77% of Carnegie Investment Counsel's portfolio in Q2 2026, its #27 holding.
- Carnegie Investment Counsel first reported a position in UnitedHealth in Q3 2015 and has held it in 44 quarters since.
- Carnegie Investment Counsel's UnitedHealth position peaked at $49.7M in Q1 2025.
- 1,660 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.
Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.